Ann: Half Year Accounts, page-91

First 91 Last

Share
Profile

Follow
jcurve

4,231 Posts.

1467

27/05/19

17:26

Post #: 38765728
Share

Originally posted by 1Down_5Up ↑

Thanks jcurve, Great to watch Prof Meiri's talk. Went through his lab web-page too. Its good to see CGB is aligned with him. one thing Prof says struck me.. last 5000 years humans used cannabis as a medication and but we stopped using it in medicine in the last decade. Only now we are seeing the potential of it.

Great part of Meiri's research might be isolation of specific compounds and to look at the effectiveness of them in clinical use for a specific disease. Wonder what is the nature of the agreement is between CGB and the research group? Hope CGB can capture lot IP out of this research and be ready to market isolated compounds or even license them to other manufactures to market them.

I wish CGB could keep investors and potential investors up to date with the research they are involved in. potential is there but it is nothing without proper execution. Lets hope the management can get things listed and get things moving along soon.

Expand

Absolutely agree @1Down_5Up
I think his approach in regard to isolating compounds and assessing the efficacy of each is a point of difference that sets him apart from almost all other researchers I’ve read about.
An excellent strategy.
To me, CGB’s investment in his research is one of the most appealing things about the company.

CGB Price at posting: 3.7¢ Sentiment: None Disclosure: Held
4 Upvote

2 Great analysis

Reply

Top Stories

Superannuation Essentials: Building Wealth for Your Retirement

WTC

A sex scandal is unlikely to hurt Australia's tech crown jewel – just look at trades

BTH

Bigtincan bounces 9% after $409M merger proposal sets stage for Nasdaq listing

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

KAU

Kaiser Reef sets up $8M capital raising to boost expansion at A1 gold mine